Novo Nordisk is working on a new oral weight loss pill that could significantly impact the market: The company plans to file for regulatory approval in the United States in the coming months. If approved, the drug could be launched as early as next year, potentially giving Novo Nordisk an advantage in the competitive weight loss drug market
Discover how we can elevate your portfolio and deliver exceptional growth. NEW Monthly Payout Of At Least 0.5% In US Dollars
AlgoTrader 